Laboratorios Leon Farma, S.A. (manufacturing of intermediate product (soft capsules Dutasteride 0.5 mg) and finished medicinal product, primary and secondary packaging; quality control and batch release)

The drug is intended for the treatment of moderate to severe symptoms of benign prostatic hyperplasia. It helps reduce the risk of acute urinary retention and lowers the likelihood of the need for surgical intervention.

Dosage form: capsules, hard

ATC: G04CA52